Sponsoring Agency HHS
    POP 1/15/15 - 1/14/25 (9 years)


This Master IDIQ, under the auspices of the NIH, National Institute of Neurological Disorders and Stroke (NINDS), and as part of the BPN, supports the development and manufacture of dosage forms (e.g., including and not limited to parenteral, oral solutions, tablets, capsules, and ocular delivery systems) of small molecule drug candidates suitable for administration in preclinical efficacy studies, Investigational new drug (IND) enabling studies, and clinical trials. Work under the proposed contract will include process development and preparation of active pharmaceutical ingredients (API), pre-formulation and formulation studies, physical and chemical characterizations, analytical method development and validation, stability studies, drug product manufacturing, packaging, storage, quality control, regulatory documentation, and distribution of the drug products.

  • $2.6m Aggregate Dollars Obligated
  • $2.6m Aggregate Base & Exercised Options
  • $2.6m Aggregate Base & All Options (Ceiling)

Market Stats Related Contracts